Participants in the structured nutrition
therapy arm of the study reduced A1C by an average of 0.67 percent and reduced body weight by an average of 3.5 Kg over 16 weeks.
Not exact matches
For the Muscle Tendon Tissue Unit Repair and Reinforcement Reconstructive Surgery Research
Study, which was sponsored by the U.S. Department
of Defense, 11 men and two women who had lost at least 25 percent
of leg or
arm muscle volume and function first underwent a customized regimen
of physical
therapy for four to 16 weeks.
Orchestrating a successful immune attack against tumors has proven difficult so far, but a new
study from MIT suggests that such
therapies could be improved by simultaneously activating both
arms of the immune system.
Joseph Poole, M.D., Ph.D.,
of the Emory University School
of Medicine, Atlanta, and colleagues
studied whether
therapy with granulocyte - macrophage colony stimulating factor (GM - CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form
of vascular disease in which there is partial or total blockage
of an artery, usually one leading to a leg or
arm).
Armed with this knowledge, and the results
of an initial feasibility
study, the Dream Team will conduct a clinical trial to evaluate if personalized
therapy, based on the genetic profile
of each individual patient's cancer, improves outcomes.